|
Update on the pharmacotherapy for myelodysplastic syndromes
|
Jul 2014
|
Expert Opin Pharmacother
|
myelodysplastic syndromes (MDS)
|
|
Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria
|
Dec 2016
|
Hematology Am Soc Hematol Educ Program
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Update in paroxysmal nocturnal hemoglobinuria
|
Jun 2012
|
Clin Adv Hematol Oncol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Unveiling the paradoxical nature of myelodysplastic syndromes (MDS): Why hypercellular marrow strongly favors accelerated apoptosis.
|
Mar 2013
|
Biochem Cell Biol
|
myelodysplastic syndromes (MDS)
|
|
Unrelated Hematopoietic Cell Transplantation in Aplastic Anemia: There Is More to a Successful Outcome Than Meets the Eye
|
May 2015
|
JAMA Oncol
|
aplastic anemia
|
|
Unrelated cord blood transplantation in a child with very severe aplastic anemia
|
Dec 2012
|
Rinsho Ketsueki
|
aplastic anemia
|
|
Unraveling Myelodysplastic Syndromes: Current Knowledge and Future Directions
|
Jan 2016
|
Curr Oncol Rep
|
myelodysplastic syndromes (MDS)
|
|
Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia
|
May 2018
|
Biol Blood Marrow Transplant
|
acute myeloid leukemia (AML)
|
|
Under-recognition of Platelet dysfunction in Myelodysplastic Syndromes: are we only seeing the tip of the iceberg?
|
Aug 2012
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Treatment sequence of lenalidomide and hypomethylating agents and the impact on clinical outcomes for patients with myelodysplastic syndromes.
|
Jan 2019
|
Leuk Lymphoma.
|
myelodysplastic syndromes (MDS)
|
